Healthcare · Hepatitis B prevalence
Iran's hepatitis B prevalence is 1.2 %, a moderate level for the Middle East. Universal infant vaccination introduced in 1993 has sharply reduced carriage among the young, but older generations—especially in rural Gilan and Mazandaran—still bear traces of infection acquired through traditional medical practices in childhood.
Data for 2026 · unit: %
Position
#76 / 197
Iran world ranking
Country position on the scale from last to first place for this indicator.
IR
#76
#197#1
Trend
Change over time
Change in indicator over the available period.
3.5
1990
2.5
2000
1.8
2010
1.3
2020
1.2
2026
Values — %
Comparison
Top countries by Hepatitis B prevalence
Where Iran stands in the world ranking.
1
GBUnited Kingdom
0.1
1
USUSA
0.1
1
NONorway
0.1
1
SESweden
0.1
1
ISIceland
0.1
1
VAVatican City
0.1
7
NLNetherlands
0.2
7
BEBelgium
0.2
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Hepatitis B prevalence in Iran — how much?
Based on 2026 data — 1.2 %. This is rank #76 out of 197 countries.
What is Iran's rank by Hepatitis B prevalence?
Iran ranks #76 out of 197 countries in the world ranking by «Hepatitis B prevalence».
How has Hepatitis B prevalence changed in Iran?
Over the available period the indicator changed from 3.5 to 1.2 %.